Clinical trials
Terminated Observational Epilepsy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| LivaNova | 2 |
| University Hospital, Lille | 2 |
| Weill Medical College of Cornell University | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Brain Sentinel | 1 |
| Carlos Pena, PhD, MS | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Children's Hospital of Philadelphia | 1 |
| Commissariat A L'energie Atomique | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 30 |
| Seizures | 5 |
| Parkinson Disease | 3 |
| Drug Resistant Epilepsy | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Alzheimer Disease | 1 |
| Anemia, Sickle Cell | 1 |
| Auditory Perceptual Disorders | 1 |
| Autism Spectrum Disorder | 1 |
| Brain Injuries, Traumatic | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.